Table of Contents: Primary Angioplasty :

Primary Angioplasty : A Practical Guide.

Bibliographic Details
Main Author:	Watson, Timothy J.
Other Authors:	Ong, Paul Jl., Tcheng, James E.
Format:	eBook
Language:	English
Published:	Singapore : Springer Singapore Pte. Limited, 2018.
Edition:	1st ed.
Subjects:	Electronic books.
Online Access:	Click to View

Table of Contents:

Intro
Preface
Acknowledgments
Contents
About the Editors
1: Historical Perspectives on Management of Acute Myocardial Infarction
1.1 Introduction
1.2 Angina Pectoris as a Clinical Entity
1.3 Development of the Electrocardiogram
1.4 Evolving Concepts in Pathophysiology of Myocardial Infarction
1.5 Cardiopulmonary Resuscitation and External Defibrillation
1.6 The Coronary Care Unit
1.7 Concept of Reduction of Infarct Size
1.8 Advent of Thrombolysis and Role of Aspirin
1.9 Coronary Angiography and Percutaneous Revascularization
1.10 Progress of Adjunctive Pharmacotherapy
1.10.1 Beta Blockade
1.10.2 ACE Inhibitors
1.10.3 HMG Co-A Reductase Inhibitors
1.10.4 Thienopyridines
1.10.5 Glycoprotein IIb/IIIa Inhibitors
References
2: Prehospital Diagnosis and Management of Acute Myocardial Infarction
2.1 Introduction
2.2 Activation of Emergency Services
2.2.1 The Call for Help
2.2.2 First Medical Contact
2.3 Diagnosis of Myocardial Infarction
2.3.1 History and Examination
2.3.2 ECG Diagnosis
2.3.3 Cardiac Biomarkers
2.4 Prehospital Treatment of Myocardial Infarction
2.4.1 Principles of Prehospital Therapy
2.4.2 Antiplatelet Therapy
2.4.3 Anticoagulants
2.4.4 GP IIb/IIIa Inhibitors
2.4.5 Fibrinolytic Therapy
2.4.6 Role of PCI After Fibrinolytic Therapy
2.4.7 Safe Transfer to the Heart Attack Centre
2.4.8 Oxygen Therapy in Acute Myocardial Infarction
2.5 Summary
References
3: Primary Angioplasty: Efficacy and Outcomes
3.1 Introduction
3.2 Treatment of STEMI
3.3 Fibrinolytic Therapy
3.4 Late Presentation PPCI
3.5 Door-To-Balloon Time (D2B)
3.6 Time from First Medical Contact with the Healthcare System (System Delay)
3.7 Direct Transfer from the Community.
3.8 The Door-In to Door-Out (DIDO) Time
3.9 Non-system Factors Leading to Delay
3.10 What Is New in the ESC 2017 Guidelines on AMI-STEMI? New/Revised Concepts
3.11 Summary
Further Readings
4: ST-Elevation Myocardial Infarction Networks and Logistics: Rural and Urban
4.1 Introduction
4.2 Organisation of a Regional ST-Elevation Myocardial Infarction Network
4.3 Emergency Medical Service
4.4 Primary Care Service or Non-primary Percutaneous Coronary Intervention Centre
4.5 Emergency Department at a Primary Percutaneous Coronary Intervention Centre
4.6 Cardiac Catheterisation Laboratory
4.7 Implementation of a Regional ST-elevation Myocardial Infarction Network
4.8 Quality Control
4.9 Case Study
4.10 Summary
Further Readings
5: Utilization of PCI After Fibrinolysis
5.1 Introduction
5.2 Fibrinolytic Therapy
5.3 PCI-Based Approaches
5.3.1 Rescue PCI
5.3.2 Facilitated PCI
5.3.3 Pharmacoinvasive
5.4 Antiplatelet Therapy as Adjunct to Fibrinolysis
5.5 Optimal Timing of PCI After Fibrinolytic Therapy
References
6: Catheter Laboratory Design, Staffing and Training
6.1 Introduction
6.2 Personnel: The "Cath Laboratory Team"
6.2.1 Education
6.2.2 The Workforce
6.2.2.1 Nursing Staff
6.2.2.2 Allied Healthcare Professionals
6.2.2.3 Radiographer
6.2.2.4 Physiologist
6.2.3 Structure and Location of the Catheter Laboratory
6.2.3.1 Location
6.2.3.2 Staff Facilities
6.2.4 The Catheter Laboratory
6.2.4.1 Entrance
6.2.4.2 Control Room
6.2.5 The Procedure Room
6.2.5.1 Safe Practice
6.2.5.2 Clinical Preparation Areas
6.2.5.3 Radiation
6.3 Protective Equipment
6.3.1 Lead Gowns
6.4 Equipment
6.4.1 X-Ray Equipment
6.4.1.1 Image Intensifier
6.4.1.2 Examination Table.
6.4.1.3 Monitors
6.4.1.4 Work Surfaces
6.4.2 Storage
6.4.2.1 Drugs
6.4.2.2 Consumables
6.4.2.3 IT Equipment
6.4.2.4 Emergency Equipment
6.4.2.5 Defibrillator
6.4.2.6 Pacing Equipment
6.4.2.7 Mechanical Chest Compression Device
6.4.2.8 Intra-aortic Balloon Pump (IABP)
6.4.2.9 Ventricular Support Devices
6.4.3 Adjunctive Devices
6.4.3.1 Rotational Atherectomy
6.4.3.2 Intravascular Imaging: Optical Coherence Tomography (OCT) and Intravascular Ultrasound (IVUS)
References
7: Patient Preparation, Vascular Access, and Guiding Catheter Selection
7.1 Patient Preparation
7.1.1 Changing Clothes
7.1.2 Medication
7.1.2.1 Dual Antiplatelet Therapy
7.1.2.2 Metformin
7.1.3 Contrast Medium Allergy
7.1.4 Chronic Kidney Disease
7.1.5 Anemia
7.1.6 Blood Pressure/Oxygen Saturation Monitor/Venous Route
7.1.7 Emergency Cases
7.2 Vascular Access
7.2.1 Access site
7.2.2 Sheath Size
7.2.3 Femoral Artery Puncture
7.2.4 Radial Artery Puncture
7.2.4.1 Ultrasound-Guided Radial Puncture
7.2.4.2 Infrared Light-guided Puncture
7.2.5 Radial Artery Puncture in Cardiopulmonary Arrest
7.2.5.1 Angiography-guided Radial Artery Puncture
7.2.5.2 Kenzan Technique
7.2.6 Distal Radial Artery Puncture/Proximal Palm Artery Puncture
7.3 Guiding Catheter Selection
7.4 Left Coronary Artery
7.4.1 Judkins Left
7.4.2 Ikari Left
7.4.2.1 Engagement Maneuver of Ikari Left
7.4.2.2 Tips to Increase Backup Force in Ikari L (Power Position)
7.4.2.3 Size of Ikari L
7.4.3 Long-tip Catheters as Voda/EBU/XB Type
7.4.4 Right Coronary Artery
7.4.4.1 Ikari L for Right Coronary Artery
7.4.4.2 Amplatz L for Right Coronary Artery
7.5 Benefits of Universal Guiding Catheters
7.6 Case Report: Primary PCI Using an Ikari Guide.
7.6.1 Introduction
7.6.2 Case Report
7.6.3 Summary
References
8: Dual Antiplatelet and Glycoprotein Inhibitors in Emergency PCI
8.1 Introduction
8.2 Aspirin
8.2.1 Evidence of Aspirin in Myocardial Infarction and PCI
8.2.2 Aspirin Dosing
8.3 P2Y12 Inhibitors
8.3.1 Evidence for P2Y12 Inhibitor in MI and PCI
8.3.2 P2Y12 Inhibitor Dosing
8.4 Glycoprotein IIb/IIIa Inhibitors
8.4.1 Evidence for GPIIb/IIIa Inhibitors in MI and PCI
8.4.2 Dosing
8.5 Recommended Treatment Algorithms from Consensus Guidelines [14, 15]
8.6 Summary
References
9: Anticoagulants and Primary PCI
9.1 Introduction
9.2 Rationale for the Use of Anticoagulant Therapy
9.3 Classes of Anticoagulant
9.3.1 Unfractionated Heparin and STEMI
9.3.2 Low-molecular Weight Heparins and STEMI
9.3.3 Direct Thrombin Inhibitors and STEMI
9.4 Monitoring of Intensity of Anticoagulation in the Cardiac Catheterization Laboratory
9.4.1 Unfractionated Heparin
9.4.2 Low Molecular Weight Heparin
9.4.3 Bivalirudin
9.5 Approach to the Patient Who Has Received Anticoagulation Prior to Primary PCI
9.6 Role of Anticoagulation Following Successful PCI
9.7 Summary
References
10: Management of Intracoronary Thrombus
10.1 Introduction
10.2 Pathophysiology of Intracoronary Thrombus Formation
10.2.1 Grading Coronary Thrombus
10.2.2 Intracoronary Thrombus and Clinical Outcomes
10.3 Management
10.3.1 Pharmacological Interventions
10.4 Thrombectomy
10.4.1 Thrombectomy Systems
10.4.2 Suggested Technique for Manual Thrombectomy
10.5 Other Causes of Intracoronary Thrombus Formation in STEMI Patients
10.6 Stenting Strategy
10.6.1 Deferred Stenting
10.7 Conclusion
10.8 Case Report: Heavy Thrombus Load in Primary PCI
10.8.1 History.
10.8.2 Management
10.8.3 Outcome
10.9 Acute STEMI with Extensive Thrombus: An Illustrative Case
10.9.1 Introduction
10.9.2 Case Report
10.9.3 Discussion
References
11: Is There a Role for Bare-Metal Stents in Current STEMI Care?
11.1 Introduction
11.2 Bare-Metal Stents
11.3 Drug-Eluting Stents
11.3.1 Anti-proliferative Drugs
11.3.2 Polymers
11.4 DES vs. BMS for Primary PCI
11.4.1 Stent Thrombosis
11.4.2 DAPT Duration
11.4.3 Atrial Fibrillation
11.4.4 Elderly Patients
11.4.5 Cost
11.5 Summary and Recommendations
11.6 Case Report: Primary PCI with Direct Stenting in Patient with Inferior Myocardial Infarction
11.6.1 Introduction
Further Readings
12: Drug-Coated Balloons in STEMI
12.1 Introduction
12.2 Drug-coated Balloons
12.3 Evidence for DCB Angioplasty in PPCI
12.3.1 No Mortality Benefit with Stents
12.3.2 Risk of Stent Thrombosis
12.3.3 Inadequate Time to Know Patient's History
12.3.4 Avoidance of Long Stents in PPCI
12.4 Technical Tips and Tricks with DCB-Only Angioplasty in Primary PCI
12.4.1 Lesion Preparation
12.4.2 Drug Delivery
12.5 Conclusion
12.6 Primary PCI of RCA with Drug-Coated Balloon Angioplasty
12.6.1 History
12.6.2 Baseline Coronary Angiography
12.6.3 Procedure
12.6.4 Restudy Angiogram
References
13: Culprit-Only Artery Versus Multivessel Disease
13.1 Introduction
13.1.1 Revascularization Strategies for STEMI Patients with MV CAD
13.1.2 Randomized Trials
13.1.2.1 PRAMI
13.1.2.2 CvLPRIT
13.1.2.3 DANAMI-3 PRIMULTI
13.1.2.4 COMPARE-ACUTE Trial
13.1.3 Safety of Complete Revascularization
13.1.4 Timing of Revascularization
13.1.5 Trials on the Horizon
13.2 State of the Art: Current Recommendations
13.3 Role of Fractional Flow Reserve.
13.4 Prognostic Value of Complete Revascularization.

Primary Angioplasty : A Practical Guide.

Similar Items